<DOC>
	<DOCNO>NCT00766675</DOCNO>
	<brief_summary>The purpose study evaluate analgesic effect combination tramadol hydrochloride acetaminophen participant treatment fibromyalgia pain ( chronic widespread pain presence tender point ) .</brief_summary>
	<brief_title>An Efficacy Study Combination Tramadol Acetaminophen Tablets Treatment Participants With Fibromyalgia Pain</brief_title>
	<detailed_description>This open-label ( people know identity intervention ) multi-center ( conducted one center ) study combination tramadol hydrochloride acetaminophen treatment participant pain fibromyalgia . The duration study 56 day per participant . The study consist 2 part : Screening ( , 3 week study commences Day 1 ) Treatment ( , Day 56 ) . All eligible participant receive oral tablet combination tramadol hydrochloride acetaminophen . Rescue medication ( medication intend relieve symptom immediately ) tylenol ( 500 milligram , 6 oral tablet daily ) permit throughout study duration . Efficacy participant primarily evaluate Pain Visual Analog Scale . Participants ' safety monitor throughout study .</detailed_description>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Participants must meet American College Rheumatology 1990 criterion classification fibromyalgia ( , Participants must widespread pain [ pain three quadrant axial skeleton ] least three month pain digital palpation 11 18 tenderpoint site Female participant must pregnant , breast feed postmenopausal least one year Participant must able take oral medication Participants must complete Screening washout procedure visual analog scale score great equal 40 milliliter Fail nonopioid analgesic Participants previously fail tramadol hydrochloride therapy discontinue tramadol hydrochloride due adverse event Participants diagnose either active connective tissue musculoskeletal disease , malignancy history malignancy within past 5 year , painful , symptomatic osteoarthritis , regional periarticular pain syndrome , spondyloarthropathy major endocrine disease Participants currently severe pain pain fibromyalgia Participants take antidepressant , cyclobenzaprine antiepileptic drug pain within three week Treatment Phase Participants take shortacting analgesic , topical medication anesthetic and/or muscle relaxant period le 21 day give medication prior Treatment Phase</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Pain</keyword>
	<keyword>Fibromyalgia</keyword>
	<keyword>Ultracet</keyword>
	<keyword>Tramadol Hydrochloride</keyword>
	<keyword>Acetaminophen</keyword>
</DOC>